Evogene
EVGN
EVGN
46 hedge funds and large institutions have $42M invested in Evogene in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 8 closing their positions.
Holders
46
Holders Change
+13
Holders Change %
+39.39%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
16
Reduced
5
Closed
8
Calls
$1.13M
Puts
$1.53M
Net Calls
-$396K
Net Calls Change
-$396K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$3.92M |
| 2 |
2
Millennium Management
New York
|
$1.47M |
| 3 |
SM
3
Senvest Management
New York
|
$3.74M |
| 4 |
AIM
4
ARK Investment Management
St. Petersburg,
Florida
|
$24.2M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$770K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| – | – | -1,139 | Closed |
|
|
HT
52
HAP Trading
New York
| – | – | – | – |
|
|
CFGS
53
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
CI
54
Clal Insurance
Tel-Aviv,
Israel
| $0 | 1 | +1 | New |
|
55
Barclays
London,
United Kingdom
| $0 | 47 | +47 | New |
|
56
Group One Trading
Chicago,
Illinois
| $0 | 81 | +81 | New |
|